The Hepatitis B Foundation (“HBF”) is the nation’s leading nonprofit research and disease advocacy organization solely dedicated to the global problem of hepatitis B, the most common serious liver infection in the world.Hepatitis B chronically infected 400 million people worldwide, causes up to 80 percent of all liver cancers, and results in almost 1 million deaths each year.
The HBF is dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide through funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community, and the general public.
The Hepatitis B Foundation was established in 1991 with the personal support of Dr. Baruch Blumberg, who won the Nobel Prize for his discovery of the hepatitis B virus. The Foundation has since grown into a professional organization with a global reach. Today, the HBF’s research institute, the Baruch S. Blumberg Institute that was named in honor of its co-founder, represents the largest concentration of nonprofit scientists in the U.S. working on hepatitis B drug discovery and liver cancer biomarkers.
To learn more about the Hepatitis B Foundation, please visit: www.hepb.org
